Neurol. praxi. 2017;18(1):32-37 | DOI: 10.36290/neu.2017.060

Multiple sclerosis in borderline age groups – childhood and elderly population

MUDr. Olga Zapletalová
Neurologická klinika FN Ostrava, Lékařská fakulta OU Ostrava

Pathological autoimmune processes with the development of inflammatory and neurodegenerative changes that meet the criteria

for a clinically isolated syndrome or definite multiple sclerosis (MS) affects mainly young adults aged 18 to 30 years. Despite of

this MS onset during childhood or adolescence is now increasingly recognized in the same way as MS in subjects over 50 years

age. There are published the first clinical sign of MS in patients over 80 years. The clinical characteristics of patients with early and

late onset MS in these age groups have their own characteristics and sometimes discreet specific signs which are not only in the

clinical course but also in magnetic resonance imaging and in testing of cerebrospinal fluid.

Keywords: sclerosis multiplex, infantile multiple sclerosis, juvenile multiple sclerosis, late-onset multiple sclerosis, acute disseminated encefalomyelitis

Published: March 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zapletalová O. Multiple sclerosis in borderline age groups – childhood and elderly population. Neurol. praxi. 2017;18(1):32-37. doi: 10.36290/neu.2017.060.
Download citation

References

  1. Banwell B. Multiple sclerosis in children. Mult Scler Relat Disord 2012; 1: 3-5. Go to original source... Go to PubMed...
  2. Banwell B, Bar-Or A, Arnold DL, Sadovnick D, Narayanan S, McGowan M, O'Mahony J, Magalhaes S, Hanwell H, Vieth R, Tellier R, Vincent T, Disanto G, Ebers G, Wambera K, Connolly MB, Yager J, Mah JK Booth F, Sebire G, Callen D, Meaney B, Dilenge ME, Lortie A, Pohl D, Doja A, Venketaswaran S, Levin S, Macdonald EA, Meek D, Wood E, Lowry N, Buckley D, Yim C, Awuku M, Cooper P, Grand'maison F, Baird JB, Bhan V, Marrie RA. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 2011; 10: 436-445. Go to original source...
  3. Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007; 6: 887-902. Go to original source...
  4. Bove R, M, Healy B, Augustine A, Musallam A, Gholiopour T, Chitnis T. Effect of tender on late-onset multiple sclerosis. Multiple Sclerosis Journal 2012; 18(10): 1472-1479. Go to original source... Go to PubMed...
  5. Chitnis T, Tenembaum S, Banwell B, Krupp L, Pohl D, Rostasy K, Yeh EA, Bykova O, Wassmer E, Tardieu M, Kornberg A, Ghezzi A; International Pediatric Multiple Sclerosis Study Group. Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler 2012; 18: 116-127. Go to original source... Go to PubMed...
  6. Dale RC, Brilot F, Banwell B. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol 2009; 22: 233-240. Go to original source... Go to PubMed...
  7. Etermadifar M, Abtahi SH, Minagar A, Akbari M, Masaeli A, Tabrizi N. Late-onset multiple sclerosis in Isfahan, Iran. Arch Iran Med 2012; 15: 596-598.
  8. Kis B, Rumberg B, Berlit P. Clinical characteristics of patiens with late-onset multiple sclerosis. J Neurol 2008; 255: 697-702. Go to original source... Go to PubMed...
  9. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68: S7-S12. Go to original source...
  10. Minden SL, Frankel D, Hadden LS, Srinath KP, Perloff JN. Disability in elderly people with multiple sclerosis: An analysis of baseline data from the Sonya Slifka Longitudinal Multiple Sclerosis Study. NeuroRehabilitation 2004; 19: 55-67. Go to original source...
  11. Menkes JH, Sarnat HB, Maria BL. Child Neurology, Lippincott Williams & Wilkins, 2006: 1186.
  12. Munger KL, Chitnis T, Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology. 2009; 73: 1543-1550. Go to original source... Go to PubMed...
  13. Pohl D, Waubant E, Banwell B, Chabas D, Chitnis T, Weinstock-Guttman B, Tenembaum S, International Pediatric MS Study Group. Treatment of pediatric multiple sclerosis and variants. Neurology 2007; 68: S54-S65. Go to original source... Go to PubMed...
  14. Polliack ML, Barak Y, Achiron A. Late-onset multiple sclerosis. J Am Geriatr Soc 2001; 49: 168-171. Go to original source... Go to PubMed...
  15. Rubin JP, Kuntz NL. Diagnostic criteria for pediatric multiple sclerosis. Curr Neurol Neurosci Rep 2013; 13: 354. Go to original source... Go to PubMed...
  16. Schultheiss T, Reichmann H, Ziemssen T. Rapidly progressive course of very late onset multiple sclerosis presenting with Parkinsonism: case report. Mult Scler 2011; 17: 245-249. Go to original source... Go to PubMed...
  17. Simone IL, Carrara D, Tortorella C, Liguori M, Lepore V, Pellegrini F, Bellacosa A, Ceccarelli A, Pavone I, Livrea P. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology 2002; 59: 1922-1928. Go to original source... Go to PubMed...
  18. Sorkin L, Molton I, Johnson K, Smith A, Stern M. Assessment and management of the elderly patient with multiple sclerosis. Healthy Aging Clin Care Elder [online] 2012; 4: 1-11. [cit. 2016-07-26]. Dostupný z WWW: http://www.la-press.com/assessment-and-management-of-the-elderly-patient-with-multiple-scleros-article-a3035. Go to original source...
  19. Takeuchi T, Ogura M, Sato M, Kawai N, Tanihata H, Takasaka I, Minamiguchi H, Nakai M, Itakura T. Late-onset tumefactive multiple sclerosis. Radiat Med 2008; 26: 549-552. Go to original source...
  20. Taláb R, Talábová M. Roztroušená skleróza u pacientů v adolescentním věku. Neurol. praxi 2013; 14: 144-149.
  21. Tenembaum SN. Treatment of multiple sclerosis and neuromyelitis optica in children and adolescents. Clin Neurol Neurosurg 2013; 115: S21-S29. Go to original source... Go to PubMed...
  22. Tremlett H, Devonshire V. Is late-onset multiple sclerosis associated with a worse outcome? Neurology 2006; 67: 954-959. Go to original source... Go to PubMed...
  23. Vargas-Lowy D, Chitnis T. Pathogenesis of pediatric multiple sclerosis. J Child Neurol 2012; 27: 1394-1407. Go to original source... Go to PubMed...
  24. Waubant E, Chabas D, Okuda DT, Glenn O, Mowry E, Henry RG, Strober JB, Soares B, Wintermark M, Pelletier D. Difference in disease burden and activity in pediatric patiens on brain magnetic resonance paging at time of multiple sclerosis onset vs adults. Arch Neurol 2009; 66: 967-971. Go to original source...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.